Enfermedades infecciosas y del sistema inmunitario

Tuberculosis

Javier Aznar Martín
IBiS
Campus Hospital Universitario Virgen del Rocío
Avda. Manuel Siurot, s/n.
41013 · Sevilla

Laboratorio: 207

Javier Aznar Martín

Volver al programa
  1. Miembros del grupo
  2. Áreas de trabajo
  3. Publicaciones

Grupo: Tuberculosis

Directorio
Miembros del grupo Tuberculosis
  • Artacho Reinoso, Mª José .Lda. en Farmacia
  • Aznar Martín, Javier.Doctor en Medicina y Cirugía. Catedrático/Jefe de Servicio (Univ. de Sevilla/HUVR).
  • Gómez Gómez, María José.Lda. en Farmacia. FEA (HUVR).
  • González Galán, Verónica.Doctora en Microbiología. FEA (HUVR).
  • Lepe Jiménez, José Antonio.Doctor en Farmacia. Jefe de Sección (HUVR).
  • Martín Gómez, Giovanna.MIR HUVR
  • Martín Gutiérrez, Guillermo.Ldo. en Biología
  • Merino Díaz, Laura.Doctora en Farmacia. FEA (HUVR).
  • Navarro Martinez, Verónica.Técnico Superior de Laboratorio
  • Porras González, Ana.Lda. en Medicina y Cirugía
  • Prieto Márquez, Ana Isabel.Doctora en Biología
  • Redero Cascón, Mª del Mar.Lda. en Medicina y Cirugía
  • Ruiz Castillo, Ana.Lda. en Farmacia
  • Ruiz Pérez de Pipaón, Maite.Doctora en Farmacia. FEA (HUVR).
  • Torres Sánchez, Mª José.Doctora en Biología. Profesora (Univ. de Sevilla).
  • Vidal Acuña , M de los Reyes.

Áreas de trabajo

Main lines of research

  • Mycobacterial infections

Development and clinical validation of a rapid method to study the antimicrobial activity against M.tuberculosis.

Development and clinical validation of a rapid against non-tuberculous Mycobacteria (MNT) of rapid growth

  • Animal tuberculosis
  • Fungal infections

Development and clinical validation of a new database for the identification of Aspergillus spp using mass spectrometry.

  • Molecular epidemiology of nosocomial and community acquired infections

Evolution of invasive pneumococcal disease and nasopharyngeal carriage among Andalusian children after the introduction of PCV13 universal childhood vaccination

  • New therapeutic approaches to special infectious diseases.

New strategies in the treatment of Listeria monocytogenes infections

Evaluation of the potential use of pyocins in the treatment of multiresistant Pseudomonas aeruginosa infections

  • Urinary tract infections

In vivo urinary tract infection murine model.

Revistas Internacionales
Barasona JA, Vicente J, Díez-Delgado I, Aznar J, Gortázar C, Torres MJ.
Environmental Presence of Mycobacterium tuberculosis Complex in Aggregation Points at the Wildlife/Livestock Interface.
Transbound Emerg Dis. 2017 Aug;64(4):1148-1158.
Castañeda-García A, Prieto AI, Rodríguez-Beltrán J, Alonso N, Cantillon D, Costas C, Pérez-Lago L, Zegeye ED, Herranz M, Plociński P, Tonjum T, García de Viedma D, Paget M, Waddell SJ, Rojas AM, Doherty AJ, Blázquez .J.
A non-canonical mismatch repair pathway in prokaryotes.
Nat Commun. 2017 Jan 27;8:14246.
Molina J, Peñalva G, Gil-Navarro MV, Praena J, Lepe JA, Pérez-Moreno MA, Ferrándiz C, Aldabó T, Aguilar M, Olbrich P, Jiménez-Mejías ME, Gascón ML, Amaya-Villar R, Neth O, Rodríguez-Hernández MJ, Gutiérrez-Pizarraya A, Garnacho-Montero J, Montero C, Cano J, Palomino J, Valencia R, Álvarez R, Cordero E, Herrero M, Cisneros JM, PRIOAM team
Long-Term Impact of an Educational Antimicrobial Stewardship Program on Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections: A Quasi-Experimental Study of Interrupted Time-Series Analysis.
Clin Infect Dis. 2017 Nov 29;65(12):1992-1999.
Delgado-Valverde M, Valiente-Méndez A, Torres E, Almirante B, Gómez-Zorrilla S, Borrell N, Aller-García AI, Gurgui M, Almela M, Sanz M, Bou G, Martínez-Martínez L, Cantón R, Lepe J, Causse M, Gutiérrez-Gutiérrez B, Pascual Á, Rodríguez-Baño J, REIPI/GEIH-SEIMC BACTERAEMIA-MIC Group.
Identification of clinical isolates of Aspergillus species by Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
J Antimicrob Chemother. 2017 May 1;72(5):1478-1487.
Martín-Gutiérrez G, Martín-Pérez C, Gutiérrez-Pizarraya A, Lepe JA, Cisneros JM, Aznar J.
Time to positivity of blood cultures in patients with bloodstream infections: A useful prognostic tool.
Enferm Infecc Microbiol Clin. 2017 Dec;35(10):638-644.
Pupo I, Lepe JA, Smani Y, Aznar J.
Comparison of the in vitro activity of ampicillin and moxifloxacin against Listeria monocytogenes at achievable concentrations at the central nervous system.
Medical Microbiol. 2017. JMM-D-17-00015R2.
Redero M, López-Causapé C, Aznar J, Oliver A, Blazquez J, Prieto A.
Susceptibility to R-pyocins in Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients.
Journal of Antimicrobial Chemotherapy. JAC-2018-0264.R1
Nowak J, Zander E, Stefanik D, Higgins PG, Roca I, Vila J, McConnell MJ, Cisneros JM, Seifert H, MagicBullet Working Group WP4
High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial.
J Antimicrob Chemother. 2017 Dec 1;72(12):3277-3282.
Rodríguez-Villodres Á, Ortiz de la Rosa JM, Álvarez Marín R, Pachón J, Aznar J, Lepe JA, and Smani Y.
Heteroresistance to piperacillin/tazobactam in clinical isolates of Escherichia coli ST131
Antimicrobial Agents and Chemotherapy AAC01923-17.2017.
Martín-Gutiérrez G, Docobo-Perez F, Rodríguez-Beltrán J, Rodriguez-Martinez JM, Aznar J, Pascual A, and Blazquez J.
Urinary tract conditions affect fosfomycin activity against Escherichia coli strains harboring chromosomal mutations involved in fosfomycin uptake
Antimicrobial Agents and Chemotherapy AAC1899-17.2017.
Martín-Gutiérrez G, Rodríguez-Martínez JM, Pascual Á, Rodríguez-Beltrán J, Blázquez J.
Plasmidic qnr Genes Confer Clinical Resistance to Ciprofloxacin under Urinary Tract Physiological Conditions.
Antimicrob Agents Chemother. 2017 Mar 24;61(4).